Kayne Anderson BDC, Inc.
Kayne Anderson BDC, Inc. (KBDC) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Kayne Anderson BDC, Inc. (KBDC), covering cash flow, earnings, and balance sheets.
Kayne Anderson BDC, Inc. (KBDC) Income Statement & Financial Overview
Review Kayne Anderson BDC, Inc. KBDC income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $32.35M | $32.55M | $52.31M | $46.49M |
| Cost of Revenue | $0.00 | $0.00 | $3.78M | $6.15M |
| Gross Profit | $32.35M | $32.55M | $48.53M | $40.34M |
| Gross Profit Ratio | $1.00 | $1.00 | $0.93 | $0.87 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.24M | $1.12M | $1.04M | $882000.00 |
| Operating Expenses | -$3.81M | $32.55M | $28.11M | $625000.00 |
| Total Costs & Expenses | -$3.81M | $32.55M | $7.90M | $3.08M |
| Interest Income | $55.87M | $57.54M | $51.99M | $46.24M |
| Interest Expense | $15.61M | $15.12M | $12.31M | $15.66M |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $0.00 |
| EBITDA | $52.001M | $0.00 | $44.42M | $43.41M |
| EBITDA Ratio | $1.61 | $0.00 | $0.85 | $0.93 |
| Operating Income | $36.17M | -$105.36M | $45.35M | $43.41M |
| Operating Income Ratio | $1.12 | -$3.24 | $0.87 | $0.93 |
| Other Income/Expenses (Net) | $0.00 | $142.91M | -$14.17M | -$16.55M |
| Income Before Tax | $36.17M | $37.56M | $31.18M | $27.75M |
| Income Before Tax Ratio | $1.12 | $1.15 | $0.60 | $0.60 |
| Income Tax Expense | $717000.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $35.45M | $37.56M | $31.18M | $27.75M |
| Net Income Ratio | $1.10 | $1.15 | $0.60 | $0.60 |
| EPS | $0.50 | $0.53 | $0.44 | $0.43 |
| Diluted EPS | $0.50 | $0.53 | $0.44 | $0.43 |
| Weighted Avg Shares Outstanding | $71.03M | $71.08M | $71.12M | $65.02M |
| Weighted Avg Shares Outstanding (Diluted) | $71.03M | $71.08M | $71.12M | $65.02M |
Over the past four quarters, Kayne Anderson BDC, Inc. demonstrated steady revenue growth, increasing from $46.49M in Q1 2024 to $32.35M in Q4 2024. Operating income reached $36.17M in Q4 2024, maintaining a consistent 112% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $52.001M, reflecting operational efficiency. Net income dropped to $35.45M, with EPS at $0.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan